Avian reticuloendotheliosis virus (REV-T) is a replication-defective retrovirus that transforms very immature lymphoid cells and induces a fatal lymphomatosis within 7-10 days. REV-T is the only retrovirus which immortalizes cells and converts them to a tumorigenic state in a helper virus independent fashion. REV-T contains a single oncogene, v-rel, which is distinct from all other known oncogenes and is responsible for transformation. Uninfected vertebrate cells and Drosophila contain a sequence related to the v-rel oncogene. Polyclonal antisera to the v-rel protein synthesized in E. coli immunoprecipitates a phosphoprotein with a molecular weight of 57 kDa which is located in the cytosol of transformed cells. Preliminary studies indicate that the v-rel protein may possess Mn+ dependent protein kinase activity capable of autophosphorylation. One of our specific aims will be to characterize the enzymes activity associated with the v-rel protein. To demonstrate whether the kinase activity is intrinsic to v-rel protein the entire v-rel gene and deletion mutants will be expressed in E. coli and the products assaysed for kinase activity. Deletion mutants which lack kinase activity will also be tested for their ability to transform lymphoid cells in vitro. We will determine whether the transforming protein is a serine/threonine or tyrosine protein kinase. We propose to identify potential cellular substrates of the v-rel kinase. Monoclonal antibodies will be developed to characterize functional domains and identify potential cellular substrates. A correlation has been observed between REV-T provirus copy number, level of v-rel transcription, and extent of immunoglobulin gene rearrangements in REV-T transformed lymphoid cells. We propose to define whether the level of v-rel expression indirectly influences the phenotype of the REV-T transformed lymphoid cells. We propose to identify the produce of the c-rel proto-oncogene and compare its enzyme activity and substrate specificity to the viral transforming protein. The expression of c-rel will also be studied during early avian embryogenesis to define its role in the control of cell proliferation and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA033192-06
Application #
3171137
Study Section
Experimental Virology Study Section (EVR)
Project Start
1984-01-01
Project End
1989-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Texas Austin
Department
Type
Schools of Arts and Sciences
DUNS #
City
Austin
State
TX
Country
United States
Zip Code
78713
Hrdli?ková, Radmila; Nehyba, Ji?í; Bargmann, William et al. (2014) Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway. PLoS One 9:e86990
Hrdlickova, Radmila; Nehyba, Jiri; Lim, Shu Ly et al. (2012) Insights into the evolution of mammalian telomerase: platypus TERT shares similarities with genes of birds and other reptiles and localizes on sex chromosomes. BMC Genomics 13:216
Hrdlickova, Radmila; Nehyba, Jiri; Bose Jr, Henry R (2012) Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation. Mol Cell Biol 32:4283-96
Tiwari, Richa; Bargmann, William; Bose Jr, Henry R (2011) Activation of the TGF-ýý/Smad signaling pathway in oncogenic transformation by v-Rel. Virology 413:60-71
Liss, A S; Tiwari, R; Kralova, J et al. (2010) Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis. Oncogene 29:4925-37
Kralova, J; Sheely, J I; Liss, A S et al. (2010) ERK and JNK activation is essential for oncogenic transformation by v-Rel. Oncogene 29:6267-79
Nehyba, Jiri; Hrdlickova, Radmila; Bose, Henry R (2009) Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family. Mol Biol Evol 26:2539-50
Hrdlickova, Radmila; Nehyba, Jiri; Bose Jr, Henry R (2009) Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells. Mol Cell Biol 29:929-41
Tong, S; Liss, A S; You, M et al. (2007) The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation. Oncogene 26:2318-29
Hrdlickova, Radmila; Nehyba, Jiri; Liss, Andrew S et al. (2006) Mechanism of telomerase activation by v-Rel and its contribution to transformation. J Virol 80:281-95

Showing the most recent 10 out of 50 publications